Measuring Regulatory/Quality Team Member Performance
Jun 3, 2026 - 62:20
Radio and PodcastLive Radio & PodcastsHealth
3 Most Common Premarket (Postmarket?) Review Issues FDA Sees
In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences , we’re highlighting comments made by FDA representatives at an event about the most common premarket review issu...
About This Episode
3 Most Common Premarket (Postmarket?) Review Issues FDA Sees is an episode from Medtech Matters by Medical Product Outsourcing. In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences , we’...
Podcast
This episode belongs to Medtech Matters.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jun 25, 2025, 53:16 long, audio available.
Related Episodes
Continue listening to more episodes from Medtech Matters.
FDA's Third-Party Review Program
May 14, 2026 - 61:00
Triaging Your QMS: Considerations Based on the New QMSR
Apr 17, 2026 - 59:19
A Deep Dive into E&L and Biocomp Testing
Mar 11, 2026 - 22:09
Planning for FDA Shutdowns Now and in the Future
Oct 27, 2025 - 57:28
Should Wellness Products Come with a Warning?
Sep 11, 2025 - 66:02
Why Are One-Third of MAUDE Reports a Problem?
Jun 10, 2025 - 58:10
FDA Guidance on Off-Label Communication, Part 1
May 30, 2025 - 51:40